Trial Profile
A prospective, multicenter, randomized, placebo-controlled trial of physiologic testosterone supplementation for HIV-positive men with mildly to moderately reduced serum testosterone levels and abdominal obesity
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Nov 2021
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications HIV infections
- Focus Pharmacodynamics
- 03 Apr 2012 Actual end date (Mar 2006) added as reported by ClinicalTrials.gov.
- 12 Oct 2005 New trial record.